Conveners
New experimental developments in hadrontherapy: New experimental developments in hadrontherapy
- Daria Boscolo (GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany)
The main rationale for using protons in cancer treatment is based on the highly conformal dose distribution and normal tissue spearing compared to conventional radiotherapy. One of the main limits of proton therapy is the particle range uncertainty due to patient setup, dose calculation and imaging. A mispositioning potentially translates into an under-dosage of the tumor as well as an...
Purpose: An innovative detector based on thin silicon UFSD detectors was developed and characterized by the medical physics group of the University and INFN-Torinofor single ion discrimination and ion counting in a therapeutic particle beam.
Materials and Methods: Thin silicon sensors were developed, characterized and used in a prototype detector aiming at discriminating and counting single...